CLICK HERE TO READ

The inevitable changes that come with a new administration are raising questions about the PMTA and the future of THR in America. But the responsibility to self-regulate, prioritize youth protection, and uphold scientific standards exist independently of the regulatory pathway and it is precisely these voluntary commitments to rigor and transparency that will separate credible, lasting companies from those that fade from the public memory. While some may view uncertainty as a

Join ARAC and  Global Action to End Smoking (GA)  in New York City TONIGHT at the  Harvard Club of New York City . This event aims to highlight the potential of integrating tobacco harm reduction into the clinical setting, focusing on the role of clinicians in educating patients about reduced-risk products and helping them QUIT SMOKING. • Clinicians — nurses, social workers, physicians, and more — are critical in guiding patients toward effective, safer alternatives. • Expand

Celebrate 30 Years of Innovation at  TabExpo  in Geneva, Switzerland. Inspired by our global partners, ARAC actively seeks face-to-face collaboration with innovators and disruptors in the tobacco and nicotine space. Dedicated to supporting our partners' commercial success. With deep regulatory expertise and global experience, we help bring compliant, reduced-risk products to market around the world. Brought to you from TABEXPO, the launch of NOVEL NICOTINE EXPO 2025, a new tr

TUNE-IN for a LIVE REPLAY >>> "‍OWNiT: Entrepreneurship in Nicotine and Tobacco" at  American Tobacco & Nicotine Forum (ATNF) :  WATCH HERE >>>  https://lnkd.in/e5ZM6VHa KEY TAKEAWAYS: Embracing planning, risk-taking, and resilience is crucial for personal growth and success, especially for women navigating challenges in male-dominated fields. Women thrive in supportive communities, and leaders can enhance organizational culture by embracing diversity, while personal and p

Last week at  American Tobacco & Nicotine Forum (ATNF) ,  Applied Research and Analysis Company (ARAC) ’s CEO & Chief Research Officer,  Dr. Jessica Zdinak  was a MODERATOR for "Post-Market Surveillance: Balancing Innovation While Guarding Against Unintended Consequences". This panel addressed critical aspects of the PMTA process, emphasizing the need for effective regulatory frameworks amidst recent authorization challenges. WATCH the LIVE REPLAY >>>  https://lnkd.in/ep_Ku5J

The tobacco and nicotine regulatory landscape is shifting — and like many of you, we’re reevaluating how best to move forward.  At ARAC, we’re closely monitoring the evolving political, legal, and scientific signals that affect your ability to bring products to market. Our team includes deep regulatory insiders and creative scientific thinkers who are working daily to interpret what these changes mean — and what steps you should take now to stay ahead.  Let’s be honest: there

ARAC is in Milan, Italy this week attending  EVO NXT ! DAY 1 was an incredible start to the event — great conversations, industry insights, and an electric atmosphere of innovation! Today our CEO & Chief Research Officer,  Dr. Jessica Zdinak , took the stage to present on "Regulatory Pathways to Market: What Drives Global Product Success? Considerations from the Oral Nicotine Sector". LIVE REPLAY coming soon -- VIEW PRESENTATION HERE:  https://lnkd.in/eHSymT2A This afternoon,

I have always wanted to help people and the decision to become a nurse came easily to me. My nursing career began in labor and delivery, where I spent 8 years providing care to women in some of the happiest, and sometimes the most difficult, moments of their lives. Being a nurse is more than just administering medical care. Providing comprehensive care for a patient means developing a holistic understanding of an individual - not only as a patient but also as a person. Nursin

On January 16, 2025, the FDA’s Center for Tobacco Products (CTP) authorized the marketing request for 20 Zyn pouch products. The authorized products included several flavors beyond the tobacco and mint/menthol profiles that have characterized successful PMTA applicants’ products thus far. The Marketing Granted Order (MGO) therefore marks a turning point for tobacco and nicotine product regulation in the USA. The Zyn TPL provides insight into the FDA’s thinking on this topic a

As the prevalence of cigarette smoking has declined in the USA, residual smoking has become concentrated in historically disadvantaged groups, including those on lower incomes, those with lower levels of educational attainment, some racial/ethnic minorities, and the LGBTQ+ community. Smoking rates are also higher among rural, southern, and disabled communities; those experiencing housing insecurity, and those with diagnoses for mental health conditions, or a history of incarc

Bringing nicotine pouches into the highly regulated US market can be challenging.  Join our Founder & Chief Research Officer,  Dr. Jessica Zdinak , and fellow panelists at  EVO NXT ! G lobal Institute for Novel Nicotine (GINN)  is featuring a Masterclass ‘ Navigating the Introduction of Nicotine Pouches into the US Market ’ at EVO NXT on 3-4 April. REGISTER HERE.